Assignee
COHBAR INC
US·4 granted patents·12 pending applications·7 citations·filing 2017–2022
Top patents by PatentIndex Score
16 records- 0183US11111271B2Therapeutic peptidesCOHBAR INC·Filed 2017·Granted Sep 7, 2021·6 cites·33 claims
- 0282US11332497B2Therapeutic peptidesCOHBAR INC·Filed 2021·Granted May 17, 2022·1 cites·28 claims
- 0368US11753445B2Therapeutic peptidesCOHBAR INC·Filed 2022·Granted Sep 12, 2023·0 cites·31 claims
- 0458US2023372434A1Method of treating fibrosis with a combination therapyCOHBAR INC·Filed 2021·Application pending·0 cites
- 0555US2024034753A1Therapeutic peptidesCOHBAR INC·Filed 2021·Application pending·0 cites
- 0655US2023218710A1Method of treating coronavirus infectionsCOHBAR INC·Filed 2021·Application pending·0 cites
- 0753US2022332774A1Therapeutic mitochondrial peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 0853US2022395553A1Cxcr4 antagonist peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 0952US11517608B2Peptide-containing formulationsCOHBAR INC·Filed 2019·Granted Dec 6, 2022·0 cites·15 claims
- 1052US2022324912A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1152US2022324911A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1251US2022306691A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1351US2022324925A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1451US2022305079A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1551US2022324909A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
- 1651US2022226484A1Therapeutic peptidesCOHBAR INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →